Innovations in cell-free gene synthesis decrease turnaround times for obtaining full-length, complex, NGS-verified DNA from weeks or months to as few as 6-8 business days. Cell-free DNA speeds ...

Aldevron unveiled Alchemy™ cell-free DNA technology. The technology was designed to support development and preclinical programs, with a future cGMP offering expected to launch in 2025 to ...

(Graphic: Business Wire) Alchemy cell-free DNA technology is now available at research grade, providing researchers with a faster, more efficient method to produce high-quality DNA templates.

For the new cell-free DNA testing, a small amount of a person's blood is tested for a large number of cancers. A positive test could indicate that the person has a certain type of cancer in theory ...

A new blood test utilizing cell-free DNA from the placenta can predict preterm preeclampsia with 80% accuracy. This condition, causing significant maternal and fetal mortality, has been difficult ...

Apart from sequencing cell-free DNA fragments, researchers can also obtain information about methylation states and expression patterns. Scientists combine these data to understand the pathogenic ...

Cell-Free Fetal DNA Testing MarketThe global cell-free fetal DNA testing market is experiencing robust growth, with revenue projected to climb from USD 1,566.0 million in 2024 to USD 3,051.5 million ...

Use of a standardized cell-free (cf)DNA-sequencing and cancer-screening protocol detected cancer in nearly half of pregnant or postpartum women who initially received unusual or nonreportable ...

Donor-derived cell-free DNA (dd-cfDNA) is a non-invasive biomarker that permits early diagnosis of antibody-mediated rejection (AMR) in kidney transplant recipients with de novo anti-HLA donor ...

Cell-free DNA (cfDNA) sequence analysis to screen for fetal aneuploidy can incidentally detect maternal cancer. Additional data are needed to identify DNA-sequencing patterns and other biomarkers ...

Aldevron’s Alchemy™ is an exclusive cell-free DNA technology which cuts research grade linear DNA manufacturing time by over 50 percent, accelerating mRNA development projects with cleaner ...